OpenOnco
UA EN
Plan Builder Prevention Onco Wiki Tumor Board

For worried people, not only oncologists

Check risk, family history, screenings, and early warning signs.

Answer a few structured questions. OpenOnco will not diagnose cancer; it will prioritize what to discuss with a doctor, which routine screenings may be due, and whether family history suggests genetic counseling.

This is not a diagnosis and not a replacement for a clinician.
Browser-only. Do not enter names, phone numbers, addresses, or identifiers.

What successful products taught us

The redesign borrows the parts that work in high-growth cancer-prevention products: simple intake, clear risk lanes, family-history capture, navigation to the next action, and honesty that new tests complement routine screening.

Color Health Integrated virtual cancer care: early detection, personalized guidance, clinical follow-up. CancerIQ Risk assessment, genetic screening, and patient navigation as one health-system workflow. Freenome Early detection framed as multimodal signals rather than one magic test. GRAIL Galleri MCED positioning is additive: it does not replace routine recommended screening. Prenuvo Consumer demand for proactive checks, visual results, and a guided next step.

Your check

1. About you
2. What worries you right now

Select persistent, unexplained, or new findings.

3. Screening status

Approximate is enough. This does not replace local screening rules.

4. Family history / pedigree
5. Risk factors and exposures
6. Existing diagnostic data

Evidence anchors

Guidelines used for routing

CDC family history Family history helps decide which screening tests may be needed, when to start, and whether genetic counseling/testing is appropriate. NCI genetic testing Genetic counseling is generally recommended before inherited cancer-risk testing. USPSTF breast Biennial mammography for women aged 40 to 74. USPSTF colorectal Screen adults aged 45 to 75 for colorectal cancer. USPSTF lung Annual LDCT for adults aged 50 to 80 with at least 20 pack-years who smoke or quit within 15 years. USPSTF cervical Cervical screening from 21 to 65 with cytology and/or HPV strategies by age.

Market patterns reviewed

Color Health Integrated virtual cancer care: early detection, personalized guidance, clinical follow-up. CancerIQ Risk assessment, genetic screening, and patient navigation as one health-system workflow. Freenome Early detection framed as multimodal signals rather than one magic test. GRAIL Galleri MCED positioning is additive: it does not replace routine recommended screening. Prenuvo Consumer demand for proactive checks, visual results, and a guided next step.